Register for our free email digests:
Division of Johnson & Johnson
Latest From Sirigen Group Ltd.
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
Medtronic opens Shanghai innovation center. Justice Department ICD investigation nears resolution. BD buys dye maker Sirigen. More news briefs.
- Implantable Devices
- Surgical Equipment & Devices
- Therapeutic Areas
- Musculoskeletal & Connective Tissue Disorders
- Western Europe
- Parent & Subsidiaries
- Johnson & Johnson
- Senior Management
Michel Orsinger, Pres. & CEO
Robert Donohue, CFO
- Contact Info
Phone: (41) 32 720 40 60
Glutz Blotzheim-Str. 1-3
Solothurn , 4500
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.